ATE503838T1 - Ortspezifische verabreichung von aktiven substanzen im darm - Google Patents

Ortspezifische verabreichung von aktiven substanzen im darm

Info

Publication number
ATE503838T1
ATE503838T1 AT03759088T AT03759088T ATE503838T1 AT E503838 T1 ATE503838 T1 AT E503838T1 AT 03759088 T AT03759088 T AT 03759088T AT 03759088 T AT03759088 T AT 03759088T AT E503838 T1 ATE503838 T1 AT E503838T1
Authority
AT
Austria
Prior art keywords
active substances
site
intestinal
specific administration
biologically active
Prior art date
Application number
AT03759088T
Other languages
English (en)
Inventor
Peter Bron
Vos Willem De
Michiel Kleerebezem
Original Assignee
Friesland Brands Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friesland Brands Bv filed Critical Friesland Brands Bv
Application granted granted Critical
Publication of ATE503838T1 publication Critical patent/ATE503838T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03759088T 2003-10-28 2003-10-28 Ortspezifische verabreichung von aktiven substanzen im darm ATE503838T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2003/000733 WO2005040387A1 (en) 2003-10-28 2003-10-28 Site-specific intestinal delivery and/or production of biologically active substances

Publications (1)

Publication Number Publication Date
ATE503838T1 true ATE503838T1 (de) 2011-04-15

Family

ID=34511318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03759088T ATE503838T1 (de) 2003-10-28 2003-10-28 Ortspezifische verabreichung von aktiven substanzen im darm

Country Status (6)

Country Link
EP (1) EP1680508B1 (de)
AT (1) ATE503838T1 (de)
AU (1) AU2003274831A1 (de)
DE (1) DE60336596D1 (de)
TW (1) TW200514848A (de)
WO (1) WO2005040387A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891967B1 (de) * 2006-08-24 2019-11-20 Société des Produits Nestlé S.A. Flavonoid enthaltende Zusammensetzung mit lang anhaltender Absorption
EP1972350A1 (de) * 2007-03-20 2008-09-24 Rijksuniversiteit Groningen Duales Targeting-System
WO2011059332A2 (en) 2009-11-16 2011-05-19 Stichting Top Institute Food And Nutrition Improved immunomodulation by probiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423367D0 (en) * 1994-11-18 1995-01-11 Wellcome Found Enzyme prodrug therapy
WO1996032486A1 (en) * 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
GB9718616D0 (en) * 1997-09-02 1997-11-05 Queen Mary & Westfield College Oral vaccine
EP1084709A1 (de) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oraler Impfstoff enthaltend rekombinanten Lactobacilli
AU2003218833A1 (en) * 2002-03-11 2003-09-22 Wageningen Centre For Food Sciences Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance

Also Published As

Publication number Publication date
TW200514848A (en) 2005-05-01
EP1680508B1 (de) 2011-03-30
EP1680508A1 (de) 2006-07-19
AU2003274831A1 (en) 2005-05-11
WO2005040387A1 (en) 2005-05-06
DE60336596D1 (de) 2011-05-12

Similar Documents

Publication Publication Date Title
CY1110488T1 (el) Μεθοδος για την παρασκευη καρβοξυ-τερματικων αμιδουχων πεπτιδιων
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
NO20052956D0 (no) Defensinprotiner
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2006046073A3 (en) C1q related protein
NO20070780L (no) Celloverflateprotein.
TW200724679A (en) Treatment of disease using an improved regulated expression system
ATE503838T1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
UA91136C2 (ru) Системы, фармацевтическая композиция на его основе и способ ее применения
BRPI0418359A (pt) método simplificado para recuperar quitosana a partir de suas soluções ácidas
IL169256A0 (en) Metalloprotease proteins
DOP2006000117A (es) Terapia génica de interferon-beta usando un sistema mejorado de expresión regulada
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
AR056831A1 (es) Metodo para el diagnostico y tratamiento de enfermedades cardiovasculares
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
WO2001049839A3 (en) Method for expressing gene and use thereof
WO2006051333A3 (en) Leucine-rich repeat (lrr) motif containing proteins
WO2007049062A3 (en) Vwfa-domain containing proteins
TH93866A (th) องค์ประกอบที่มีกรดโดโคซาเพนทาอีโนอิค
WO2004056863A8 (en) Splice variant of human placental growth hormone
FR2863497B1 (fr) Nouvelles compositions pharmaceutiques et/ou dietetiques contre le stress
UY29543A1 (es) Terapia génica de interferon-beta usando un sistema mejorado de expresión regulada
DE60039540D1 (de) Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration
MXPA05012414A (es) Proteina secretada similar a tnf.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties